BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 18602768)

  • 1. DNA demethylation induced by the methyl-CpG-binding domain protein MBD3.
    Brown SE; Suderman MJ; Hallett M; Szyf M
    Gene; 2008 Sep; 420(2):99-106. PubMed ID: 18602768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic programming of the rRNA promoter by MBD3.
    Brown SE; Szyf M
    Mol Cell Biol; 2007 Jul; 27(13):4938-52. PubMed ID: 17452452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methyl-CpG binding domain proteins and their involvement in the regulation of the MAGE-A1, MAGE-A2, MAGE-A3, and MAGE-A12 gene promoters.
    Wischnewski F; Friese O; Pantel K; Schwarzenbach H
    Mol Cancer Res; 2007 Jul; 5(7):749-59. PubMed ID: 17634428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome.
    Weber M; Hellmann I; Stadler MB; Ramos L; Pääbo S; Rebhan M; Schübeler D
    Nat Genet; 2007 Apr; 39(4):457-66. PubMed ID: 17334365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of methyl CpG-binding domain containing factor MBD3 in the developing and adult rat brain.
    Jung BP; Zhang G; Nitsch R; Trogadis J; Nag S; Eubanks JH
    J Neurobiol; 2003 May; 55(2):220-32. PubMed ID: 12672019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methyl-CpG-binding proteins in cancer: blaming the DNA methylation messenger.
    Ballestar E; Esteller M
    Biochem Cell Biol; 2005 Jun; 83(3):374-84. PubMed ID: 15959563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stage- and site-specific DNA demethylation during neural cell development from embryonic stem cells.
    Shimozaki K; Namihira M; Nakashima K; Taga T
    J Neurochem; 2005 Apr; 93(2):432-9. PubMed ID: 15816866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homocysteine regulates expression of Herp by DNA methylation involving the AARE and CREB binding sites.
    Lenz B; Bleich S; Beutler S; Schlierf B; Schwager K; Reulbach U; Kornhuber J; Bönsch D
    Exp Cell Res; 2006 Dec; 312(20):4049-55. PubMed ID: 17020760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential recruitment of methylated CpG binding domains by the orphan receptor GCNF initiates the repression and silencing of Oct4 expression.
    Gu P; Le Menuet D; Chung AC; Cooney AJ
    Mol Cell Biol; 2006 Dec; 26(24):9471-83. PubMed ID: 17030610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MBD3 mediates epigenetic regulation on EPAS1 promoter in cancer.
    Cui J; Duan B; Zhao X; Chen Y; Sun S; Deng W; Zhang Y; Du J; Chen Y; Gu L
    Tumour Biol; 2016 Oct; 37(10):13455-13467. PubMed ID: 27465550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global, comparative analysis of tissue-specific promoter CpG methylation.
    Schilling E; Rehli M
    Genomics; 2007 Sep; 90(3):314-23. PubMed ID: 17582736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic changes in the localization of five members of the methyl binding domain (MBD) gene family during murine and bovine preimplantation embryo development.
    Ruddock-D'Cruz NT; Xue J; Wilson KJ; Heffernan C; Prashadkumar S; Cooney MA; Sanchez-Partida LG; French AJ; Holland MK
    Mol Reprod Dev; 2008 Jan; 75(1):48-59. PubMed ID: 17546630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unmasking of epigenetically silenced candidate tumor suppressor genes by removal of methyl-CpG-binding domain proteins.
    Lopez-Serra L; Ballestar E; Ropero S; Setien F; Billard LM; Fraga MF; Lopez-Nieva P; Alaminos M; Guerrero D; Dante R; Esteller M
    Oncogene; 2008 Jun; 27(25):3556-66. PubMed ID: 18223687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a murine methyl cytosine phosphate guanine binding domain-containing factor 3 (MBD3) promoter segment sufficient for driving reporter gene expression in neurons in vitro and in vivo.
    Jung BP; Purushotham D; Eubanks JH
    Neuroscience; 2007 Mar; 145(3):1016-25. PubMed ID: 17289276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing of MBD1 and MeCP2 in prostate-cancer-derived PC3 cells produces differential gene expression profiles and cellular phenotypes.
    Yaqinuddin A; Abbas F; Naqvi SZ; Bashir MU; Qazi R; Qureshi SA
    Biosci Rep; 2008 Dec; 28(6):319-26. PubMed ID: 18666890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissecting the behavior and function of MBD3 in DNA methylation homeostasis by single-molecule spectroscopy and microscopy.
    Cui Y; Irudayaraj J
    Nucleic Acids Res; 2015 Mar; 43(6):3046-55. PubMed ID: 25753672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. cDNA cloning, expression, and characterization of methyl-CpG-binding domain type 2/3 proteins from starfish and sea urchin.
    Matsumoto M; Toraya T
    Gene; 2008 Sep; 420(2):125-34. PubMed ID: 18585872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific association between the methyl-CpG-binding domain protein 2 and the hypermethylated region of the human telomerase reverse transcriptase promoter in cancer cells.
    Chatagnon A; Bougel S; Perriaud L; Lachuer J; Benhattar J; Dante R
    Carcinogenesis; 2009 Jan; 30(1):28-34. PubMed ID: 18952593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An embryonic demethylation mechanism involving binding of transcription factors to replicating DNA.
    Matsuo K; Silke J; Georgiev O; Marti P; Giovannini N; Rungger D
    EMBO J; 1998 Mar; 17(5):1446-53. PubMed ID: 9482741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoter hypermethylation-mediated inactivation of LRRC4 in gliomas.
    Zhang Z; Li D; Wu M; Xiang B; Wang L; Zhou M; Chen P; Li X; Shen S; Li G
    BMC Mol Biol; 2008 Nov; 9():99. PubMed ID: 18976507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.